Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'expensive' on E
Target Price
The average target price of INDV is 46 and suggests 42% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell